Purchase Order HHSN269201800092P
- Not listed
- This federal contract was awarded by the Department of Health and Human Services National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company. The award has a firm fixed price contract type and a potential value of $967,646.15. It is for the provision of proprietary CliniMACS cell isolation reagents and consumables compatible with government-owned Miltenyi cell separation instruments. These products are used by the NIH Clinical Center Cell...
- This federal contract award from the Department of Health and Human Services National Institutes of Health (NIH) Clinical Center was issued to Miltenyi Biotec, Inc., a global biotechnology company that provides products and services to support biomedical research and cell and gene therapy. The $1,090,887.29 Firm Fixed Price Delivery Order contract is for the provision of proprietary CliniMACS cell isolation reagents and consumables compatible with government-owned Miltenyi cell separation...
- This $3,742.63 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract supports the delivery and installation of Miltenyi's proprietary CliniMACS cell processing system, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as associated reagents and consumables. This award is a standalone...
- The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a $1,722,610.45 firm-fixed-price delivery order contract to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of biotechnology products and services. The contract is for the provision of proprietary CliniMACS cell isolation reagents and consumables compatible with government-owned Miltenyi cell separation instruments. These reagents and kits are used by the NIH Clinical...
- The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a $248,000.00 fixed-price purchase order to Miltenyi Biotec, Inc., a global biotechnology company, for CliniMACS PLUS reagents and consumables used in the manufacture of human cell and tissue-based products for clinical trials and therapies. The NIH Clinical Center, which is responsible for producing specialized immunotherapy products for critically ill patients, requires these proprietary...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services for biomedical research and cell therapy development. The $7,009 contract supports the delivery and installation of Miltenyi Biotec's CliniMACS Prodigy cell processing system, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as...
- This $142,174 firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract is for the supply of CliniMACS Prodigy Essential Service Units to support the NIH Clinical Center's cell therapy manufacturing capabilities. This award is part of a larger $2.3 million indefinite delivery contract (IDC) that Miltenyi...
- This federal contract award, valued at $110,254.00, was issued by the Office of the Chief Operating Officer (part of the Department of Health and Human Services) to Miltenyi Biotec, Inc., a global biotechnology company. The contract is for the delivery and installation of specialized laboratory equipment, reagents, and consumables used in cell isolation, analysis, and processing. Miltenyi Biotec has extensive experience as a prime contractor for numerous federal agencies, including the...
- The U.S. National Institutes of Health (NIH) Clinical Center awarded a $71,087 firm fixed-price purchase order to Miltenyi Biotec, Inc. to provide preventative maintenance services for the agency's CliniMACS Prodigy cell processing instruments through June 1, 2026. This contract does not have a set-aside designation. Miltenyi Biotec is a global manufacturer of biomedical research and cell therapy products, including the CliniMACS line of automated cell isolation systems used by the NIH's Cell...
- The National Institutes of Health (NIH) Clinical Center awarded a Firm Fixed Price Purchase Order contract valued at $3,600.00 to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of specialized biotechnology products. The contract, which does not have a set-aside designation, runs through September 22, 2023 and provides for the delivery of Miltenyi Biotec's proprietary cell separation reagents, consumables, and technical support services to support the NIH Clinical Center's cell...
This is a federal contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract award, valued at $20,493.00, is a firm fixed-price purchase order to supply Miltenyi Biotec's proprietary CliniMACS cell isolation reagents, consumables, and related services to support the NIH's cell therapy manufacturing capabilities. This single-award indefinite delivery contract (IDC) was established in June 2023 and runs through September 2024, with options to extend to 2027. It leverages Miltenyi Biotec's position as the sole manufacturer of these specialized, FDA-approved reagents to ensure the availability of critical supplies for the NIH Clinical Center's ongoing cell therapy research and development programs. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($145) | 9/16/24 | |
| P00001 | Funding Only Action | ($11) | 9/9/24 | |
| Not listed | Not listed | $20.6k | 11/22/17 |